
Sign up to save your podcasts
Or


Brendan Frey, founder and chief innovation officer of Deep Genomics, sits down with Amar Drawid to discuss how the company is using deep learning to leverage massive RNA biology datasets to drive the development of new therapies.
By Levine Media GroupBrendan Frey, founder and chief innovation officer of Deep Genomics, sits down with Amar Drawid to discuss how the company is using deep learning to leverage massive RNA biology datasets to drive the development of new therapies.